Qianhai Health Holdings Limited (0911.HK)
HKD 0.2
(-3.33%)
HKD 0.2
(-3.33%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 478.11 Million HKD | -10.54% |
| 2022 | 534.43 Million HKD | -27.64% |
| 2021 | 738.62 Million HKD | 0.43% |
| 2020 | 735.47 Million HKD | -6.44% |
| 2019 | 786.09 Million HKD | 13.51% |
| 2018 | 692.53 Million HKD | -12.97% |
| 2017 | 795.73 Million HKD | 24.48% |
| 2016 | 639.22 Million HKD | -72.61% |
| 2015 | 2.33 Billion HKD | -25.97% |
| 2014 | 3.15 Billion HKD | 211.22% |
| 2013 | 1.01 Billion HKD | 42.48% |
| 2012 | 710.87 Million HKD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 525.26 Million HKD | 9.86% |
| 2024 Q2 | 525.26 Million HKD | 0.0% |
| 2023 Q3 | 478.11 Million HKD | 14.53% |
| 2023 Q1 | 417.47 Million HKD | -21.89% |
| 2023 FY | 478.11 Million HKD | -10.54% |
| 2023 Q2 | 417.47 Million HKD | 0.0% |
| 2023 Q4 | 478.11 Million HKD | 0.0% |
| 2022 FY | 534.43 Million HKD | -27.64% |
| 2022 Q4 | 534.43 Million HKD | 0.0% |
| 2022 Q3 | 534.43 Million HKD | -25.6% |
| 2022 Q2 | 718.32 Million HKD | 0.0% |
| 2022 Q1 | 718.32 Million HKD | -2.75% |
| 2021 FY | 738.62 Million HKD | 0.43% |
| 2021 Q4 | 738.62 Million HKD | 0.0% |
| 2021 Q2 | 752.15 Million HKD | 0.0% |
| 2021 Q3 | 738.62 Million HKD | -1.8% |
| 2021 Q1 | 752.15 Million HKD | 2.27% |
| 2020 Q3 | 735.47 Million HKD | 2.5% |
| 2020 FY | 735.47 Million HKD | -6.44% |
| 2020 Q2 | 717.53 Million HKD | 0.0% |
| 2020 Q1 | 717.53 Million HKD | -8.72% |
| 2020 Q4 | 735.47 Million HKD | 0.0% |
| 2019 FY | 786.09 Million HKD | 13.51% |
| 2019 Q4 | 786.09 Million HKD | 0.0% |
| 2019 Q3 | 786.09 Million HKD | 12.96% |
| 2019 Q1 | 695.93 Million HKD | 0.49% |
| 2019 Q2 | 695.93 Million HKD | 0.0% |
| 2018 Q1 | 724.49 Million HKD | -8.95% |
| 2018 FY | 692.53 Million HKD | -12.97% |
| 2018 Q4 | 692.53 Million HKD | 0.0% |
| 2018 Q3 | 692.53 Million HKD | -4.41% |
| 2018 Q2 | 724.49 Million HKD | 0.0% |
| 2017 Q1 | 660.96 Million HKD | 3.4% |
| 2017 Q2 | 660.96 Million HKD | 0.0% |
| 2017 FY | 795.73 Million HKD | 24.48% |
| 2017 Q3 | 795.73 Million HKD | 20.39% |
| 2017 Q4 | 795.73 Million HKD | 0.0% |
| 2016 FY | 639.22 Million HKD | -72.61% |
| 2016 Q4 | 639.22 Million HKD | 0.0% |
| 2016 Q3 | 639.22 Million HKD | -54.17% |
| 2016 Q2 | 1.39 Billion HKD | 0.0% |
| 2016 Q1 | 1.39 Billion HKD | -40.23% |
| 2015 Q3 | 2.33 Billion HKD | -36.44% |
| 2015 Q2 | 3.67 Billion HKD | 0.0% |
| 2015 Q1 | 3.67 Billion HKD | 16.48% |
| 2015 FY | 2.33 Billion HKD | -25.97% |
| 2015 Q4 | 2.33 Billion HKD | 0.0% |
| 2014 Q2 | 1.65 Billion HKD | 0.0% |
| 2014 Q1 | 1.65 Billion HKD | 63.68% |
| 2014 Q3 | 3.15 Billion HKD | 90.13% |
| 2014 Q4 | 3.15 Billion HKD | 0.0% |
| 2014 FY | 3.15 Billion HKD | 211.22% |
| 2013 Q4 | 1.01 Billion HKD | 0.0% |
| 2013 FY | 1.01 Billion HKD | 42.48% |
| 2013 Q1 | - HKD | 0.0% |
| 2013 Q3 | 1.01 Billion HKD | 0.0% |
| 2012 FY | 710.87 Million HKD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 907.46 Million HKD | 47.313% |
| Grand Pharmaceutical Group Limited | 22.51 Billion HKD | 97.876% |
| Extrawell Pharmaceutical Holdings Limited | 1.28 Billion HKD | 62.856% |
| Wai Yuen Tong Medicine Holdings Limited | 2.09 Billion HKD | 77.179% |
| Lee's Pharmaceutical Holdings Limited | 2.89 Billion HKD | 83.46% |
| Essex Bio-Technology Limited | 2.82 Billion HKD | 83.091% |
| Tongfang Kontafarma Holdings Limited | 1.72 Billion HKD | 72.321% |
| PuraPharm Corporation Limited | 843.96 Million HKD | 43.349% |
| SSY Group Limited | 11.96 Billion HKD | 96.004% |
| JBM (Healthcare) Limited | 1.38 Billion HKD | 65.571% |
| Jacobson Pharma Corporation Limited | 3.48 Billion HKD | 86.288% |
| China Resources Pharmaceutical Group Limited | 271.69 Billion HKD | 99.824% |